This Drugmaker Should Go Fishing for a Marketing Partner
Over the previous two days, we've looked at chronic weight management company VIVUS (NASDAQ: VVUS ) , and advanced prostate cancer treatment provider Dendreon (NASDAQ: DNDN ) , as two companies that missed the ball with their marketing and/or …
See all stories on this topic »
Apple's Marketing Overhaul Continues
Though 2012 was an excellent year for marketing at Samsung, it was quite the opposite at Apple (NASDAQ: AAPL ) . The company's short-lived “Genius” ads were mocked and its product-based ads were questioned. Thankfully, Apple has spent the first half of …
See all stories on this topic »
Cash for Junk Cars Philadelphia Marketing Ads From Cash for Cars Quick Hit …
The Nation's most preferred auto buyer Cash for Cars Quick releases new “cash for junk cars Philadelphia” online classified ads to boost local office. The company has added another marketing strategy to entice old car and trucks owners to sell unwanted …
See all stories on this topic »
Popular Questions
Why should this drugmaker go fishing for a marketing partner?
A marketing partner could help the drugmaker reach physicians, patients, and healthcare organizations more effectively. An experienced partner may bring specialized knowledge of pharmaceutical advertising rules, market research, and digital campaign execution. The drugmaker should compare partners based on regulatory expertise, audience access, measurable results, and experience promoting similar therapies.
What should this drugmaker look for when choosing a marketing partner?
The drugmaker should seek a partner with a strong record in pharmaceutical marketing and a clear understanding of the product’s therapeutic area. The agency should be able to support compliant messaging, medical education, patient outreach, and performance tracking. Before signing, the company should review case studies, confirm approval workflows, and define specific goals for awareness, engagement, and prescription growth.
How can a marketing partner improve this drugmaker’s launch strategy?
A capable marketing partner can use market data to identify priority audiences and shape messages for each stage of the product launch. It can coordinate brand, digital, public relations, and patient-support efforts so that campaigns reach people consistently. The drugmaker should require regular reporting on reach, qualified engagement, conversion activity, and compliance issues, then adjust the strategy based on those results.
What risks should the drugmaker manage when partnering on marketing?
The drugmaker must ensure that every claim, advertisement, and educational asset meets applicable healthcare advertising and regulatory requirements. It should establish clear responsibilities for medical, legal, and regulatory review before any campaign goes live. A written agreement should also address data privacy, ownership of creative work, performance standards, confidentiality, and procedures for correcting inaccurate or noncompliant material.